Windlas Biotech Ltd
NSE:WINDLAS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medicamen Biotech Ltd
NSE:MEDICAMEQ
|
IN |
|
Verra Mobility Corp
NASDAQ:VRRM
|
US |
|
NWS Holdings Ltd
HKEX:659
|
HK |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
US |
|
Gentex Corp
NASDAQ:GNTX
|
US |
|
New China Life Insurance Company Ltd
SSE:601336
|
CN |
|
G
|
Grainturk Tarim AS
IST:GRTRK.E
|
TR |
|
Calibre Mining Corp
TSX:CXB
|
CA |
|
X
|
Xinjiang Tianrun Dairy Co Ltd
SSE:600419
|
CN |
|
H
|
Hongcheng Environmental Technology Co Ltd
HKEX:2265
|
CN |
|
F
|
Filinvest REIT Corp
XPHS:FILRT
|
PH |
Windlas Biotech Ltd
Research & Development
Windlas Biotech Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Windlas Biotech Ltd
NSE:WINDLAS
|
Research & Development
-₹62.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Syngene International Ltd
NSE:SYNGENE
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
|
Research & Development
-₹20.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sai Life Sciences Ltd
NSE:SAILIFE
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Anthem Biosciences Ltd
NSE:ANTHEM
|
Research & Development
-₹195.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Windlas Biotech Ltd
Glance View
Windlas Biotech Ltd. operates as a contract development and manufacturing organization (CDMO). The firm provides a range of contract development and manufacturing organization (CDMO) services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics. Its therapeutic categories, such as, anti-diabetic, cardiovascular, neuropsychiatry and respiratory therapies. The Company’s service capabilities include formulation development, technology scale-up and full-scale commercial manufacturing. The company has capabilities for both solid and liquid pharmaceutical dosage forms. The Company’s market its own manufactured nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities. The company also has a salesforce and distribution network spread across over 14 states. The Company’s manufacturing facilities are located at Dehradun in Uttarakhand.
See Also
What is Windlas Biotech Ltd's Research & Development?
Research & Development
-62.5m
INR
Based on the financial report for Mar 31, 2025, Windlas Biotech Ltd's Research & Development amounts to -62.5m INR.
What is Windlas Biotech Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-10%
Over the last year, the Research & Development growth was 21%. The average annual Research & Development growth rates for Windlas Biotech Ltd have been 1% over the past three years , -10% over the past five years .